193 related articles for article (PubMed ID: 26660913)
1. What do we mean by identifiability in mixed effects models?
Lavielle M; Aarons L
J Pharmacokinet Pharmacodyn; 2016 Feb; 43(1):111-22. PubMed ID: 26660913
[TBL] [Abstract][Full Text] [Related]
2. Calculating all multiple parameter solutions of ODE models to avoid biological misinterpretations.
Saccomani MP; Thomaseth K
Math Biosci Eng; 2019 Jul; 16(6):6438-6453. PubMed ID: 31698571
[TBL] [Abstract][Full Text] [Related]
3. Identifiability of large-scale non-linear dynamic network models applied to the ADM1-case study.
Nimmegeers P; Lauwers J; Telen D; Logist F; Impe JV
Math Biosci; 2017 Jun; 288():21-34. PubMed ID: 28237667
[TBL] [Abstract][Full Text] [Related]
4. Three novel approaches to structural identifiability analysis in mixed-effects models.
Janzén DLI; Jirstrand M; Chappell MJ; Evans ND
Comput Methods Programs Biomed; 2019 Apr; 171():141-152. PubMed ID: 27181677
[TBL] [Abstract][Full Text] [Related]
5. Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models.
Siripuram VK; Wright DFB; Barclay ML; Duffull SB
J Pharmacokinet Pharmacodyn; 2017 Oct; 44(5):415-423. PubMed ID: 28612141
[TBL] [Abstract][Full Text] [Related]
6. Making Predictions Using Poorly Identified Mathematical Models.
Simpson MJ; Maclaren OJ
Bull Math Biol; 2024 May; 86(7):80. PubMed ID: 38801489
[TBL] [Abstract][Full Text] [Related]
7. Parameter Identifiability of Fundamental Pharmacodynamic Models.
Janzén DL; Bergenholm L; Jirstrand M; Parkinson J; Yates J; Evans ND; Chappell MJ
Front Physiol; 2016; 7():590. PubMed ID: 27994553
[TBL] [Abstract][Full Text] [Related]
8. Parameter identifiability and model selection for sigmoid population growth models.
Simpson MJ; Browning AP; Warne DJ; Maclaren OJ; Baker RE
J Theor Biol; 2022 Feb; 535():110998. PubMed ID: 34973274
[TBL] [Abstract][Full Text] [Related]
9. A confidence building exercise in data and identifiability: Modeling cancer chemotherapy as a case study.
Eisenberg MC; Jain HV
J Theor Biol; 2017 Oct; 431():63-78. PubMed ID: 28733187
[TBL] [Abstract][Full Text] [Related]
10. Parameter estimation for multistage clonal expansion models from cancer incidence data: A practical identifiability analysis.
Brouwer AF; Meza R; Eisenberg MC
PLoS Comput Biol; 2017 Mar; 13(3):e1005431. PubMed ID: 28288156
[TBL] [Abstract][Full Text] [Related]
11. Structural identifiability and sensitivity.
Iliadis A
J Pharmacokinet Pharmacodyn; 2019 Apr; 46(2):127-135. PubMed ID: 30895420
[TBL] [Abstract][Full Text] [Related]
12. Review: To be or not to be an identifiable model. Is this a relevant question in animal science modelling?
Muñoz-Tamayo R; Puillet L; Daniel JB; Sauvant D; Martin O; Taghipoor M; Blavy P
Animal; 2018 Apr; 12(4):701-712. PubMed ID: 29096725
[TBL] [Abstract][Full Text] [Related]
13. Global identifiability of linear compartmental models--a computer algebra algorithm.
Audoly S; D'Angiò L; Saccomani MP; Cobelli C
IEEE Trans Biomed Eng; 1998 Jan; 45(1):36-47. PubMed ID: 9444838
[TBL] [Abstract][Full Text] [Related]
14. A general model-based design of experiments approach to achieve practical identifiability of pharmacokinetic and pharmacodynamic models.
Galvanin F; Ballan CC; Barolo M; Bezzo F
J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):451-67. PubMed ID: 23733369
[TBL] [Abstract][Full Text] [Related]
15. Determining identifiable parameter combinations using subset profiling.
Eisenberg MC; Hayashi MA
Math Biosci; 2014 Oct; 256():116-26. PubMed ID: 25173434
[TBL] [Abstract][Full Text] [Related]
16. Minimal experimental requirements for structural identifiability in linear compartmental models. The software 'IDEXMIN'.
Mérino JA; de Biasi J; Plusquellec Y; Houin G
Arzneimittelforschung; 1996 Mar; 46(3):324-8. PubMed ID: 8901159
[TBL] [Abstract][Full Text] [Related]
17. Statistical identifiability and convergence evaluation for nonlinear pharmacokinetic models with particle swarm optimization.
Kim S; Li L
Comput Methods Programs Biomed; 2014 Feb; 113(2):413-32. PubMed ID: 24216078
[TBL] [Abstract][Full Text] [Related]
18. Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acid.
Ogungbenro K; Aarons L
J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):279-92. PubMed ID: 21347679
[TBL] [Abstract][Full Text] [Related]
19. Structural Identifiability of Dynamic Systems Biology Models.
Villaverde AF; Barreiro A; Papachristodoulou A
PLoS Comput Biol; 2016 Oct; 12(10):e1005153. PubMed ID: 27792726
[TBL] [Abstract][Full Text] [Related]
20. DAISY: a new software tool to test global identifiability of biological and physiological systems.
Bellu G; Saccomani MP; Audoly S; D'Angiò L
Comput Methods Programs Biomed; 2007 Oct; 88(1):52-61. PubMed ID: 17707944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
